Abstract
Inflammatory bowel disease is a chronic, heterogenic, and lifelong illness with a high potential of individual and social disability. A general deterioration of the quality of life in patients with inflammatory bowel disease predominantly stems from localized complications regarding the natural course of the disease. Both Crohn’s disease (CD) and ulcerative colitis (UC) are associated with various kinds of complications. A direct causal relationship exists between disease duration and development of complications. However, CD is frequently related with the formation of fistulae and abscess due to its transmural nature, while UC is often accompanied by the results of severe inflammations such as toxic megacolon. Despite the abundant literature discussing the pathogenesis and treatment of those complications, early detection and intervention for complication is still challenging at present. Therefore, clinical evaluation should precisely characterize the number, location, degree, and feature of the complications. In this chapter, we will review about complications of gastrointestinal tract in patients with inflammatory bowel disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schwartz DA, Loftus Jr EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122(4):875–80. PubMed PMID: 11910338.
Falconi M, Pederzoli P. The relevance of gastrointestinal fistulae in clinical practice: a review. Gut. 2001;49 Suppl 4:iv2–10. PubMed PMID: 11878790. Pubmed Central PMCID: 1766897.
Tozer P, Ng SC, Siddiqui MR, Plamondon S, Burling D, Gupta A, et al. Long-term MRI-guided combined anti-TNF-alpha and thiopurine therapy for Crohn’s perianal fistulas. Inflamm Bowel Dis. 2012;18(10):1825–34. PubMed PMID: 22223472.
Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med. 1995;123(2):132–42. PubMed PMID: 7778826.
Kamm MA, Ng SC. Perianal fistulizing Crohn’s disease: a call to action. Clin Gastroenterol Hepatol. 2008;6(1):7–10. PubMed PMID: 18063415.
Fleshner PR, Schoetz Jr DJ, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Anal fissure in Crohn’s disease: a plea for aggressive management. Dis Colon Rectum. 1995;38(11):1137–43. PubMed PMID: 7587755.
Bouguen G, Siproudhis L, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Nonfistulizing perianal Crohn’s disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis. 2010;16(8):1431–42. PubMed PMID: 20310013.
Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn’s disease. Int J Color Dis. 1986;1(2):104–7. PubMed PMID: 3611935.
Hughes LE. Clinical classification of perianal Crohn’s disease. Dis Colon Rectum. 1992;35(10):928–32. PubMed PMID: 1395978.
Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB, American Gastroenterological Association Clinical Practice C. AGA technical review on perianal Crohn’s disease. Gastroenterology. 2003;125(5):1508–30. PubMed PMID: 14598268.
Bonheur JL, Braunstein J, Korelitz BI, Panagopoulos G. Anal skin tags in inflammatory bowel disease: new observations and a clinical review. Inflamm Bowel Dis. 2008;14(9):1236–9. PubMed PMID: 18452201.
Keighley MR, Eastwood D, Ambrose NS, Allan RN, Burdon DW. Incidence and microbiology of abdominal and pelvic abscess in Crohn’s disease. Gastroenterology. 1982;83(6):1271–5. PubMed PMID: 7129031.
Ayuk P, Williams N, Scott NA, Nicholson DA, Irving MH. Management of intra-abdominal abscesses in Crohn’s disease. Ann R Coll Surg Engl. 1996;78(1):5–10. PubMed PMID: 8659975. Pubmed Central PMCID: 2502682.
Kim DH, Cheon JH, Moon CM, Park JJ, Han SY, Kim ES, et al. Clinical efficacy of nonsurgical treatment of Crohn’s disease-related intrbdominal abscess. Korean J Gastroenterol. 2009;53(1):29–35. PubMed PMID: 19158468.
Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70(4):845–57. PubMed PMID: 11875755. Pubmed Central PMCID: 379113.
Thienpont C, D’Hoore A, Vermeire S, Demedts I, Bisschops R, Coremans G, et al. Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut. 2010;59(3):320–4. PubMed PMID: 19840991.
Gan SI, Beck PL. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol. 2003;98(11):2363–71. PubMed PMID: 14638335. Epub 2003/11/26. eng.
Greenstein AJ, Sachar DB, Gibas A, Schrag D, Heimann T, Janowitz HD, et al. Outcome of toxic dilatation in ulcerative and Crohn’s colitis. J Clin Gastroenterol. 1985;7(2):137–43. PubMed PMID: 4008909.
Alemayehu G, Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol. 1991;86(2):187–90. PubMed PMID: 1992632. Epub 1991/02/01. eng.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chan, H.Ch., Kim, D.H., Lung, P.F.C., Cheon, J.H., Ng, S.C. (2015). Complications of Inflammatory Bowel Disease. In: Kim, W., Cheon, J. (eds) Atlas of Inflammatory Bowel Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39423-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-39423-2_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39422-5
Online ISBN: 978-3-642-39423-2
eBook Packages: MedicineMedicine (R0)